Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose PK and PD study of varenicline nasal spray in healthy Japanese adults
jRCT2071250031Phase 1Completed
- Sponsor
- Viatris
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of varenicline in dry eye syndrome (DED), sponsored by Viatris. Primary endpoints: Pharmacokinetic data (Part A), Mean change from baseline in tear meniscus height (TMH) (Part B) and 1 more. Started May 2025; status: completed.
02
Drugs
varenicline
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2071250031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250031.